(Q35750215)

10 August 2017

1 reference

title

Hypothesis: atorvastatin has pleiotropic effects that translate into early clinical benefits on cardiovascular disease (English)

1 reference

10 August 2017

1 reference

2

Charles H Hennekens

1 reference

10 August 2017

Cristina Novela

1

1 reference

10 August 2017

1 March 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

10 August 2017

1 reference

10 August 2017

9

1 reference

10 August 2017

1

1 reference

10 August 2017

61-63

1 reference

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I109

10.1177/107424840400900I109

21 January 2018

Identifiers

DOI

1 reference

release_vnufbohwbzd6bn5ewjjmovux6m

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vnufbohwbzd6bn5ewjjmovux6m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15094970

1 reference

PubMed ID

15094970